HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms.

Abstract
A total of 102 patients with recurrent upper respiratory tract infections underwent microbiological exploration with appropriate sampling and direct biopsies of the infected sites. Therapy was then started and on day 1 each patient received two intramuscular injections of thiamphenicol glycinate acetylcysteinate (TGA). From day 2 to 10 sequential therapy with the same drug was continued employing TGA administered by aerosol. All putative etiologic agents recovered were susceptible to thiamphenicol and only 24 demonstrated the ability to produce in vitro biofilms. The organisms comprised 10 Staphylococcus aureus, 6 Streptococcus pyogenes, 4 Streptococcus pneumoniae and 3 Haemophilus influenzae. Of the 24 subjects in whom biofilms were demonstrated to be present in vivo by Scanning Electron Microscopy, clinical and bacteriological cure was obtained in 21 cases (87.5%) following sequential therapy with TGA. Failures were considered to be persistent signs and symptoms at day 15 after initiation of treatment and lack of eradication of 3 S. aureus strains, despite their in vitro susceptibility to thiamphenicol. Very few adverse events attributable to TGA were reported in this cohort of patients. In no case was discontinuation of treatment deemed necessary by the attending physician.
AuthorsA Macchi, F Ardito, A Marchese, G C Schito, G Fadda
JournalJournal of chemotherapy (Florence, Italy) (J Chemother) Vol. 18 Issue 5 Pg. 507-13 (Oct 2006) ISSN: 1120-009X [Print] Italy
PMID17127228 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Aerosols
  • Anti-Bacterial Agents
  • Drug Combinations
  • Expectorants
  • thiamphenicol glycinate acetylcysteinate
  • Thiamphenicol
  • Acetylcysteine
Topics
  • Acetylcysteine (administration & dosage, adverse effects)
  • Adolescent
  • Adult
  • Aerosols (therapeutic use)
  • Aged
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Bacterial Physiological Phenomena (drug effects)
  • Biofilms (drug effects)
  • Drug Administration Routes
  • Drug Combinations
  • Expectorants (administration & dosage, adverse effects)
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Middle Aged
  • Respiratory Tract Infections (drug therapy, microbiology)
  • Thiamphenicol (administration & dosage, adverse effects, analogs & derivatives)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: